Mike Mueller

This profile gathers the share dealings of Mike Mueller in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). We count 16 filings; the first trade dates from 31 May 2014 and the latest from 25 September 2025.

Both buying and selling appear: 6 purchases worth €16k, against 1 sale worth €6,743. Netting one side against the other leaves €9,626 of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 option exercises.

A typical purchase (the median) is worth €2,186. No cluster: in 6 purchases, no other insider of the company bought within 30 days.

Most recently, on 29 September 2025, the filings show an option exercise worth €33k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The last insider purchase was made public on 10 December 2024, 683 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.